Search
for
Sort by
Research 871–900 of 1000+
- The hair in childhood and old age
- COMPARATIVE STUDY OF TROPONIN I LEVEL IN ALOPECIA AREATA, ANDROGENIC ALOPECIA AND HEALTHY CONTROL SUBJECTS
- Polycystic Ovary Syndrome: It’s Not Just Infertility
- A systematic review and meta-analysis on the association between androgenic alopecia and the risk of metabolic syndrome
- Androgenetic Alopecia From A to Z
- The prevalence of metabolic syndrome in male patients of early onset androgenic alopecia compared to age matched controls
- Characterization of lipid profile in psoriasis, acne vulgaris, and androgenetic alopecia: a case–control study
- Relationship of androgenic alopecia with higher BMI in Pakistan: A cross sectional study
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Evaluation of the relationship between androgenetic alopecia and blood groups and Rhesus factor
- Association of Dyslipidemia and Androgenetic Alopecia: A Case Control Study
- Frequency of deranged blood lipids in male patients with androgenetic alopecia
- ASSOCIATION OF ANDROGENETIC ALOPECIA WITH METABOLIC SYNDROME
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- 133 Female Post-Finasteride Syndrome: It’s Not Just A Man’s World
- The women’s hair growth questionnaire: Development and validation of a patient-reported measure for treatment efficacy in androgenetic alopecia
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Editor's Picks
- Androgenic Alopecia and Coronary Artery Disease in Women: A Systematic Review
- Topical Minoxidil Overdose in a Young Man With Androgenetic Alopecia: A Case Report
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Особенности артериальной гипертензии у женщин: современное состояние проблемы
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- New drugs: Agalsidase beta
- Long-term reduction of C-reactive protein by LDL apheresis
- Executive Summary: Heart Disease and Stroke Statistics—2011 Update
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries